Cargando…
Establishment and characterization of CRISPR/Cas9‐mediated NF2 (−/−) human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM), a highly refractory tumor, is currently incurable due to the lack of an early diagnosis method and medication, both of which are urgently needed to improve the survival and/or quality of life of patients. NF2 is a tumor suppressor gene and is frequently mutated...
Autores principales: | Wahiduzzaman, Md, Karnan, Sivasundaram, Ota, Akinobu, Hanamura, Ichiro, Murakami, Hideki, Inoko, Akihito, Rahman, Md Lutfur, Hyodo, Toshinori, Konishi, Hiroyuki, Tsuzuki, Shinobu, Hosokawa, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317947/ https://www.ncbi.nlm.nih.gov/pubmed/30417500 http://dx.doi.org/10.1111/cas.13871 |
Ejemplares similares
-
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2020) -
Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
por: Yamaji, Masayuki, et al.
Publicado: (2017) -
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2023) -
Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells
por: Kanasugi, Jo, et al.
Publicado: (2020) -
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
por: Rahman, Md. Lutfur, et al.
Publicado: (2021)